The prevalent analyst and expert consensus on ResMed is Hold with 3 strong sell openions. The current projected target price consensus is 63.18 with 9 total expert opinions. On of the most common way ResMed Inc analysists use to generate public recommendation is conference and earning calls analysis. In addition, many experts are talking to ResMed vendors, executives, and/or customers to validate their buy or sell advice.ResMed recommendation module provides average expert sentiment on the projected ResMed Inc target price to derive its highest and lowest estimates based on target estimated volatility of 8.499. Additionally take a look at Macroaxis Advice on ResMed to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.